A biotech comany advancing tissue-selective drug delivery platform technologies to revolutionize drug development.
N1 Life has raised $10.0M in total funding. The most recent round was Seed. The last funding was announced in April 2023.
N1 Life's investors include Legend Capital, Frees Fund, Newgen Venture Partners, China Medical System Holdings Limited, Sino-Singapore Capital.
N1 Life is headquartered in Milpitas, United States.
A biotech comany advancing tissue-selective drug delivery platform technologies to revolutionize drug development.
N1 Life is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"N1 Life — Funding & Investors." VCBacked, April 17, 2023, https://www.vcbacked.co/company/n1-life. Accessed July 20, 2026.
VCBacked. (2023). N1 Life — Funding & Investors. Retrieved July 20, 2026, from https://www.vcbacked.co/company/n1-life
{{cite web |title=N1 Life — Funding & Investors |url=https://www.vcbacked.co/company/n1-life |website=VCBacked |access-date=July 20, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated